Ambra BioScience – Lovidia was formed to develop and commercialize products that deliver measurable improvement in health and wellness. Lovidia Hunger Control Formula, the first GSM-based commercial product has been shown to reduce hunger in a randomized, double-blind, placebo-controlled clinical study with 220 subjects. The Company’s flagship product, Lovidia hunger control and weight loss, is based on the Company’s patented science known as Gut Sensory Modulation or GSM. GSM involves delivering GRAS (General Recognized As Safe) dietary ingredients orally past the stomach to the lining of the gut. Lovidia’s proprietary blend of GRAS ingredients is non-stimulating, vegan, non-GMO, gluten-free and dairy-free. There are two forms of Lovidia: (1) Lovidia, which is a natural Hunger Control blend that releases over 1-3 hours in your gut and (2) Lovidia XR (Extended Release) which releases the natural blend over 3-6 hours in your gut.
Glycaemic Index A Practical Measure For Maintaining A Healthy DietGeoffreyOsullivan
An overview of methods to determine the effect of increased blood glucose after eating certain foods and linking this to desease risk and improved health
The document describes the MonaVie RVL Weight Management Program, which includes nutrient-dense shakes and bars, meal plans designed by a nutrition expert, and online support tools to help users achieve their weight loss goals through increased nutrient intake and reduced calories. The program is supported by clinical research showing that meal replacements can help with greater and longer-lasting weight loss compared to traditional dieting.
The presentation in detail covers the Glycemic index and glycemic load of various kinds of food. The standard calculation of Glycemic index and GLycemic load.
Moreover, it covers the food processing effects that can alter the glycemic load and glycemic index like gelatinization, retrogradation, cooking, annealing, etc.
Glycemic Index vs. Glycemic Load: What's the Difference? - Johanna Burani, MS...Nutrition Works, LLC
What is the difference between glycemic index and glycemic load? What does each tell about a carbohydrate? Johanna Burani, MS, RD, CDE explains these differences and the calculations involved.
[Also available with narration at http://www.EatGoodCarbs.com]
The glycemic index (GI) is a value assigned to foods based on how much they raise blood glucose levels compared to an equivalent amount of pure glucose. The GI represents the total rise in blood sugar over 2 hours after eating a food. Low GI foods raise blood sugar slowly while high GI foods cause a rapid spike. Glycemic load (GL) takes into account both a food's GI and the amount of carbohydrates per serving to estimate its effect on blood glucose levels. Common foods are classified as having a low, moderate, or high GI or GL based on established cutoff values. The standard protocol for determining a food's GI involves measuring blood glucose responses in volunteers after consuming the food.
The document discusses glycemic index (GI), a method of classifying foods based on their effect on blood glucose levels. Foods that breakdown quickly during digestion have a high GI, while foods that breakdown slowly, releasing glucose gradually, have a low GI. To determine a food's GI rating, its effect on blood glucose levels over 2 hours is measured in healthy individuals and compared to a standard food. Common foods and their GI values are provided, and factors like fiber, fat, and cooking methods that affect a food's GI are explained. Tips to lower the overall GI of daily meals include choosing whole grains, fruits and vegetables, and combining high and low GI foods.
The document discusses the Glycemic Index, which ranks foods based on how quickly they raise blood sugar levels after consumption. A high GI means blood sugar rises quickly, while a low GI means it rises slowly and stays steady. High GI foods break down rapidly, causing blood sugar fluctuations, while low GI foods break down slowly for stable blood sugar levels. However, a low GI food is not necessarily nutritious if it contains unhealthy ingredients like saturated fat or lacks nutrients. An overall balanced diet and exercise are most important for health.
This document discusses glycemic index (GI), a measure of how foods affect blood glucose levels. It provides details on GI determination, factors that influence GI values, benefits of a low GI diet, and recommendations. Specifically, it finds that a low GI diet is associated with lower blood glucose and HbA1c levels, improved lipid profiles, weight control, and decreased risk of heart disease and diabetes. The take home message encourages choosing high-fiber whole grains and fruits/veggies while limiting refined sugars and large portions of high GI foods.
Glycaemic Index A Practical Measure For Maintaining A Healthy DietGeoffreyOsullivan
An overview of methods to determine the effect of increased blood glucose after eating certain foods and linking this to desease risk and improved health
The document describes the MonaVie RVL Weight Management Program, which includes nutrient-dense shakes and bars, meal plans designed by a nutrition expert, and online support tools to help users achieve their weight loss goals through increased nutrient intake and reduced calories. The program is supported by clinical research showing that meal replacements can help with greater and longer-lasting weight loss compared to traditional dieting.
The presentation in detail covers the Glycemic index and glycemic load of various kinds of food. The standard calculation of Glycemic index and GLycemic load.
Moreover, it covers the food processing effects that can alter the glycemic load and glycemic index like gelatinization, retrogradation, cooking, annealing, etc.
Glycemic Index vs. Glycemic Load: What's the Difference? - Johanna Burani, MS...Nutrition Works, LLC
What is the difference between glycemic index and glycemic load? What does each tell about a carbohydrate? Johanna Burani, MS, RD, CDE explains these differences and the calculations involved.
[Also available with narration at http://www.EatGoodCarbs.com]
The glycemic index (GI) is a value assigned to foods based on how much they raise blood glucose levels compared to an equivalent amount of pure glucose. The GI represents the total rise in blood sugar over 2 hours after eating a food. Low GI foods raise blood sugar slowly while high GI foods cause a rapid spike. Glycemic load (GL) takes into account both a food's GI and the amount of carbohydrates per serving to estimate its effect on blood glucose levels. Common foods are classified as having a low, moderate, or high GI or GL based on established cutoff values. The standard protocol for determining a food's GI involves measuring blood glucose responses in volunteers after consuming the food.
The document discusses glycemic index (GI), a method of classifying foods based on their effect on blood glucose levels. Foods that breakdown quickly during digestion have a high GI, while foods that breakdown slowly, releasing glucose gradually, have a low GI. To determine a food's GI rating, its effect on blood glucose levels over 2 hours is measured in healthy individuals and compared to a standard food. Common foods and their GI values are provided, and factors like fiber, fat, and cooking methods that affect a food's GI are explained. Tips to lower the overall GI of daily meals include choosing whole grains, fruits and vegetables, and combining high and low GI foods.
The document discusses the Glycemic Index, which ranks foods based on how quickly they raise blood sugar levels after consumption. A high GI means blood sugar rises quickly, while a low GI means it rises slowly and stays steady. High GI foods break down rapidly, causing blood sugar fluctuations, while low GI foods break down slowly for stable blood sugar levels. However, a low GI food is not necessarily nutritious if it contains unhealthy ingredients like saturated fat or lacks nutrients. An overall balanced diet and exercise are most important for health.
This document discusses glycemic index (GI), a measure of how foods affect blood glucose levels. It provides details on GI determination, factors that influence GI values, benefits of a low GI diet, and recommendations. Specifically, it finds that a low GI diet is associated with lower blood glucose and HbA1c levels, improved lipid profiles, weight control, and decreased risk of heart disease and diabetes. The take home message encourages choosing high-fiber whole grains and fruits/veggies while limiting refined sugars and large portions of high GI foods.
The document discusses the differences between gluten and FODMAPs as causes of gastrointestinal symptoms. It summarizes studies showing that a low FODMAP diet is more effective than a gluten-free diet at reducing symptoms for most IBS patients. For a minority of patients, wheat protein may cause depression or intestinal symptoms, but these effects are more likely due to FODMAPs than gluten itself. The gluten-free trend is problematic as it may interfere with diagnosing celiac disease and providing the most effective treatment, and result in nutritional inadequacies.
1) Low glycemic index (GI) diets can help with weight management and reducing risk of heart disease by increasing satiety and reducing subsequent food intake.
2) Studies found that low GI breakfasts led to lower lunch energy intake in children and reduced appetite and increased satiety over 6 days compared to high GI meals.
3) Glycemic index is a key factor in diabetes management as it classifies carbohydrates based on their effects on blood glucose levels, and prescribing low GI diets can help with tight blood glucose control.
Das ist ein Vortrag, den Dr. Clarence P. Davis im Jahre 2007 im Rahmen eines Anti-Aging Kongresses in Paris gehalten hat. Er beinhaltet theoretisches Basis- und Hintergrundswissen zu den verschiedenen Diaettypen, sowie einige praktische Beispiele aus dem aerztlichen Alltag. Der Vortrag ist auf einem hohen Niveau und richtet sich ausschliesslich an professionelle Leser mit fundierten Vorkenntnissen.
Alvin Ibarra, Senior Scientist at DuPont Nutrition & Health presents his study on: "Polydextrose acutely reduces hunger, affects glucose metabolism, and increases GLP-1 in healthy normal-weight and overweight females".
This document promotes the products and vision of FreeLife, a company focused on healthy weight loss and wellness. It summarizes clinical studies showing that their TAIslim system, including liquid, shakes, and snacks, helped users lose an average of 22 pounds and 4 inches from their waist in 60 days, significantly more than a placebo group. The document highlights some of FreeLife's key products like GoChi juice, which has proven health benefits, and TAIslim liquid, which increases metabolic rate and fat burning.
The glycemic index is a rating system that classifies foods based on how quickly they cause increases in blood sugar levels, with a scale of 1-100. Foods with a high glycemic index of 70 or above break down rapidly, while low glycemic foods below 55 break down slowly. The glycemic load takes into account both the glycemic index and amount of carbohydrates in a food. Consuming moderate to low glycemic index foods using an 80/20 rule is recommended to control blood sugar and insulin levels and prevent health issues like diabetes.
Optimal provision of en nutrition in the icuMario Sanchez
The document discusses factors related to nutrition therapy outcomes in critically ill patients. It finds that increased calorie and protein intake from early enteral nutrition is associated with better outcomes like decreased mortality and shorter hospital stays. However, the optimal amounts may depend on the individual patient characteristics and analysis methods used. Higher calorie intake showed benefit except in young, healthy, overweight patients with short ICU stays. The document develops the NUTRIC risk assessment score to identify patients most likely to benefit from aggressive nutrition therapy based on age, comorbidities, inflammation markers, time in hospital and ICU before admission.
The low FODMAP diet for irritable bowel syndrome: from evidence to practice Robin Allen
At the end of this session, participants will
be able to:
– Describe the mechanisms of action and
evidence for the use of the low FODMAP diet
in patients with irritable bowel syndrome
– Be familiar with the concepts of the 3 phases
for implementing the low FODMAP diet
– Discuss ways in which the diet could be
modified to suit the needs of the individual
Three sentences:
Optimized Irvingia contains ingredients that target digestive enzymes involved in breaking down carbohydrates and controlling blood sugar and insulin levels after meals. The manual outlines a nine pillar approach to weight loss that includes restoring insulin sensitivity and hormone balance, controlling carbohydrate absorption, increasing metabolism, managing stress, improving sleep, and following a reduced calorie diet and exercise plan. The comprehensive program addresses the multiple factors involved in weight gain as people age in order to achieve substantial and sustained weight loss.
The document provides a comprehensive 9-pillar plan for successful long-term weight loss in aging individuals. The 9 pillars include: 1) restoring insulin sensitivity through nutrients, metformin, and calorie reduction, 2) restoring youthful hormone balance through testing and prescription of hormones as needed, 3) controlling the rate of carbohydrate absorption through fiber intake, 4) increasing metabolism and energy expenditure, 5) managing stress levels, 6) improving sleep quality, 7) increasing muscle mass, 8) following a reduced calorie diet, and 9) engaging in regular exercise. The document emphasizes that aging individuals need to implement multiple strategies simultaneously to achieve meaningful and sustainable weight loss.
Clinical Study done on GlucAffect. A product from Reliv International, a food science company - Mission: Nourish Our World. Better control and reversal of type 2 diabetes was noted. Best noted for blood sugar management.
This case study documents a nutrition assessment and care plan for an 84-year old male patient with multiple chronic conditions including rheumatoid arthritis, gout, hypertension, and an open wound. The nutrition assessment found the patient was underweight, reporting an 11% weight loss over 3 months, and had a low estimated calorie and fiber intake. The nutrition diagnosis identified involuntary weight loss due to limited access to food and increased nutrient needs for wound healing. The nutrition intervention included education on foods to avoid for gout relief and counseling to eat more frequent, nutrient-dense meals and snacks along with supplemental drinks to address the weight loss and wound healing. Follow-up would monitor the patient's diet, supplements, weight, activity level, and
This document discusses bariatric surgery as a treatment for obesity, diabetes, and hypertension - known as the "dangerous triad". It outlines the obesity epidemic globally and in India. Bariatric surgery is presented as the most effective long-term treatment, as other options like diet, exercise, and medication often only achieve temporary weight loss. The document describes various bariatric surgical procedures and their mechanisms for weight loss and resolving comorbidities. Case studies are presented demonstrating successful weight loss and comorbidity resolution through bariatric surgery. Risks are low but include leaks, strictures, and potential for weight regain. A multidisciplinary team approach is emphasized for best outcomes.
Dozens of diet plans on the market. everybody search for diets offering a way to reduce without accompanying cravings, hunger pangs, or need for heavy exertion.
This document summarizes a randomized controlled trial that compared weight loss and metabolic outcomes after 2 years on a low-carbohydrate versus low-fat diet. 307 participants were assigned to either a low-carbohydrate diet with limited carbohydrate intake (20g/day for 3 months, then increasing) or a low-fat diet with limited calorie intake (1200-1800 kcal/day). Both diets were combined with behavioral treatment. At 2 years, weight loss was similar (around 7kg) between groups. The low-carbohydrate diet resulted in greater improvements in blood lipids but also more initial side effects. Long-term weight loss requires ongoing behavioral support regardless of diet.
There are several versions of the ketogenic diet, but the standard (SKD) version that focuses on high fat and very low carb intake is the most researched and recommended. Ketosis is a metabolic state caused by lowering carb intake that causes the body to burn fat instead of carbs. Following a keto diet and intermittent fasting can help induce ketosis, and certain tests and symptoms indicate if ketosis has been achieved. A keto diet can help with weight loss and provides various health benefits like improved blood sugar control.
Can we track what we ate from our blood? From our pee?
The Nutri-Markers team from UCD are exploring this as part of the UCD-Nutrimarkers study, gaining a deeper understanding of the link between nutrition and health.
The potential for this is huge - no more food diaries for a start.
The science of nutrigenomics, metabolomics, is still very much in it's infancy, with advanced testing with DNA and blood analysis.
You can find out more on the UCD project on their website - http://www.ucdnutrimarkers.com/
Obesidad: nutrientes moduladores de neuropeptidos y neurotransmisoresNutriline SRL
This document discusses ketogenic enteral nutrition (KEN) as a treatment for obesity. It describes a study of over 19,000 obese patients who underwent 10-day cycles of receiving 50-65 grams of protein per day via continuous nasogastric tube infusion, without any carbohydrates. This protocol resulted in an average weight loss of 10.2 kg over 2.5 cycles, with 57% of the loss being fat mass. No significant adverse effects occurred. KEN is concluded to be a safe, fast, and inexpensive treatment that provides good long-term weight maintenance results.
The document discusses the differences between gluten and FODMAPs as causes of gastrointestinal symptoms. It summarizes studies showing that a low FODMAP diet is more effective than a gluten-free diet at reducing symptoms for most IBS patients. For a minority of patients, wheat protein may cause depression or intestinal symptoms, but these effects are more likely due to FODMAPs than gluten itself. The gluten-free trend is problematic as it may interfere with diagnosing celiac disease and providing the most effective treatment, and result in nutritional inadequacies.
1) Low glycemic index (GI) diets can help with weight management and reducing risk of heart disease by increasing satiety and reducing subsequent food intake.
2) Studies found that low GI breakfasts led to lower lunch energy intake in children and reduced appetite and increased satiety over 6 days compared to high GI meals.
3) Glycemic index is a key factor in diabetes management as it classifies carbohydrates based on their effects on blood glucose levels, and prescribing low GI diets can help with tight blood glucose control.
Das ist ein Vortrag, den Dr. Clarence P. Davis im Jahre 2007 im Rahmen eines Anti-Aging Kongresses in Paris gehalten hat. Er beinhaltet theoretisches Basis- und Hintergrundswissen zu den verschiedenen Diaettypen, sowie einige praktische Beispiele aus dem aerztlichen Alltag. Der Vortrag ist auf einem hohen Niveau und richtet sich ausschliesslich an professionelle Leser mit fundierten Vorkenntnissen.
Alvin Ibarra, Senior Scientist at DuPont Nutrition & Health presents his study on: "Polydextrose acutely reduces hunger, affects glucose metabolism, and increases GLP-1 in healthy normal-weight and overweight females".
This document promotes the products and vision of FreeLife, a company focused on healthy weight loss and wellness. It summarizes clinical studies showing that their TAIslim system, including liquid, shakes, and snacks, helped users lose an average of 22 pounds and 4 inches from their waist in 60 days, significantly more than a placebo group. The document highlights some of FreeLife's key products like GoChi juice, which has proven health benefits, and TAIslim liquid, which increases metabolic rate and fat burning.
The glycemic index is a rating system that classifies foods based on how quickly they cause increases in blood sugar levels, with a scale of 1-100. Foods with a high glycemic index of 70 or above break down rapidly, while low glycemic foods below 55 break down slowly. The glycemic load takes into account both the glycemic index and amount of carbohydrates in a food. Consuming moderate to low glycemic index foods using an 80/20 rule is recommended to control blood sugar and insulin levels and prevent health issues like diabetes.
Optimal provision of en nutrition in the icuMario Sanchez
The document discusses factors related to nutrition therapy outcomes in critically ill patients. It finds that increased calorie and protein intake from early enteral nutrition is associated with better outcomes like decreased mortality and shorter hospital stays. However, the optimal amounts may depend on the individual patient characteristics and analysis methods used. Higher calorie intake showed benefit except in young, healthy, overweight patients with short ICU stays. The document develops the NUTRIC risk assessment score to identify patients most likely to benefit from aggressive nutrition therapy based on age, comorbidities, inflammation markers, time in hospital and ICU before admission.
The low FODMAP diet for irritable bowel syndrome: from evidence to practice Robin Allen
At the end of this session, participants will
be able to:
– Describe the mechanisms of action and
evidence for the use of the low FODMAP diet
in patients with irritable bowel syndrome
– Be familiar with the concepts of the 3 phases
for implementing the low FODMAP diet
– Discuss ways in which the diet could be
modified to suit the needs of the individual
Three sentences:
Optimized Irvingia contains ingredients that target digestive enzymes involved in breaking down carbohydrates and controlling blood sugar and insulin levels after meals. The manual outlines a nine pillar approach to weight loss that includes restoring insulin sensitivity and hormone balance, controlling carbohydrate absorption, increasing metabolism, managing stress, improving sleep, and following a reduced calorie diet and exercise plan. The comprehensive program addresses the multiple factors involved in weight gain as people age in order to achieve substantial and sustained weight loss.
The document provides a comprehensive 9-pillar plan for successful long-term weight loss in aging individuals. The 9 pillars include: 1) restoring insulin sensitivity through nutrients, metformin, and calorie reduction, 2) restoring youthful hormone balance through testing and prescription of hormones as needed, 3) controlling the rate of carbohydrate absorption through fiber intake, 4) increasing metabolism and energy expenditure, 5) managing stress levels, 6) improving sleep quality, 7) increasing muscle mass, 8) following a reduced calorie diet, and 9) engaging in regular exercise. The document emphasizes that aging individuals need to implement multiple strategies simultaneously to achieve meaningful and sustainable weight loss.
Clinical Study done on GlucAffect. A product from Reliv International, a food science company - Mission: Nourish Our World. Better control and reversal of type 2 diabetes was noted. Best noted for blood sugar management.
This case study documents a nutrition assessment and care plan for an 84-year old male patient with multiple chronic conditions including rheumatoid arthritis, gout, hypertension, and an open wound. The nutrition assessment found the patient was underweight, reporting an 11% weight loss over 3 months, and had a low estimated calorie and fiber intake. The nutrition diagnosis identified involuntary weight loss due to limited access to food and increased nutrient needs for wound healing. The nutrition intervention included education on foods to avoid for gout relief and counseling to eat more frequent, nutrient-dense meals and snacks along with supplemental drinks to address the weight loss and wound healing. Follow-up would monitor the patient's diet, supplements, weight, activity level, and
This document discusses bariatric surgery as a treatment for obesity, diabetes, and hypertension - known as the "dangerous triad". It outlines the obesity epidemic globally and in India. Bariatric surgery is presented as the most effective long-term treatment, as other options like diet, exercise, and medication often only achieve temporary weight loss. The document describes various bariatric surgical procedures and their mechanisms for weight loss and resolving comorbidities. Case studies are presented demonstrating successful weight loss and comorbidity resolution through bariatric surgery. Risks are low but include leaks, strictures, and potential for weight regain. A multidisciplinary team approach is emphasized for best outcomes.
Dozens of diet plans on the market. everybody search for diets offering a way to reduce without accompanying cravings, hunger pangs, or need for heavy exertion.
This document summarizes a randomized controlled trial that compared weight loss and metabolic outcomes after 2 years on a low-carbohydrate versus low-fat diet. 307 participants were assigned to either a low-carbohydrate diet with limited carbohydrate intake (20g/day for 3 months, then increasing) or a low-fat diet with limited calorie intake (1200-1800 kcal/day). Both diets were combined with behavioral treatment. At 2 years, weight loss was similar (around 7kg) between groups. The low-carbohydrate diet resulted in greater improvements in blood lipids but also more initial side effects. Long-term weight loss requires ongoing behavioral support regardless of diet.
There are several versions of the ketogenic diet, but the standard (SKD) version that focuses on high fat and very low carb intake is the most researched and recommended. Ketosis is a metabolic state caused by lowering carb intake that causes the body to burn fat instead of carbs. Following a keto diet and intermittent fasting can help induce ketosis, and certain tests and symptoms indicate if ketosis has been achieved. A keto diet can help with weight loss and provides various health benefits like improved blood sugar control.
Can we track what we ate from our blood? From our pee?
The Nutri-Markers team from UCD are exploring this as part of the UCD-Nutrimarkers study, gaining a deeper understanding of the link between nutrition and health.
The potential for this is huge - no more food diaries for a start.
The science of nutrigenomics, metabolomics, is still very much in it's infancy, with advanced testing with DNA and blood analysis.
You can find out more on the UCD project on their website - http://www.ucdnutrimarkers.com/
Obesidad: nutrientes moduladores de neuropeptidos y neurotransmisoresNutriline SRL
This document discusses ketogenic enteral nutrition (KEN) as a treatment for obesity. It describes a study of over 19,000 obese patients who underwent 10-day cycles of receiving 50-65 grams of protein per day via continuous nasogastric tube infusion, without any carbohydrates. This protocol resulted in an average weight loss of 10.2 kg over 2.5 cycles, with 57% of the loss being fat mass. No significant adverse effects occurred. KEN is concluded to be a safe, fast, and inexpensive treatment that provides good long-term weight maintenance results.
Bariatric surgery, especially Roux-en-Y gastric bypass (RYGB), has been shown to be an effective treatment for type 2 diabetes, resulting in blood glucose level improvement in over 75% of cases. This improvement often occurs before significant weight loss and is attributed to changes in gastrointestinal hormones and intestinal glucose metabolism following surgery. Studies in animals and humans indicate that RYGB increases production of hormones like GLP-1 and PYY that promote satiety while decreasing ghrelin, and alters intestinal cells to break down more glucose locally before absorption into the bloodstream.
Do you know that studies have shown that probiotics goes beyond gut health? Learn more from Dr. Anders Henriksson, Principal Application Specialist through his presentation at the Food for Health Conference held in conjunction with UMass 100th anniversary.
Alicia Wong1
, Wan Chien Han1
, Elsie Low1
,
Chai Xiang Goh1
,
Siew Li Ng1
,
Lee Kuan Kwan1
Abstract: Diabetes-specific formulas have shown to be effective at improving glucose control with additional
nutritional benefits. Furthermore, diabetes-specific formulas are commonly used for diabetic patients with
insufficient oral intake. However, not much diabetes-specific formulas in the market shows the GI of these
formulas, which is clinically useful on glycemic control in patients with diabetes. The aim of this study was to
assess the GI of a newly developed diabetes-specific formula, Contro eazy NOW. The open labelled, single center
study involved 11 individuals from a pool of 18 healthy subjects. After an overnight fast, volunteers were given
Contro eazy NOW containing 50g of carbohydrate or the reference drink (glucolin) on different occasions in
random order. Postprandial blood glucose levels were measured in finger pricked capillary blood for two hours
after intake of the beverages and positive incremental area under the curve (AUC) was calculated for both Contro
eazy NOW and reference drink. The GI of Contro eazy NOW was determined by dividing AUC (Contro eazy
NOW) by the AUC (reference drink). The results show that the diabetes-specific formula has the GI of 38.4, which
is categorized as low GI. Therefore, Contro eazy NOW with low GI can be the preferred option for nutritional
management of diabetic patients in need of nutritional support.
Keywords: diabetes-specific formula, diabetes, low glycemic index, medical nutrition therapy.
This document provides an update on drugs used to treat gastroesophageal reflux disease (GORD) in infants, children, and young people. It discusses non-pharmacological treatments like thickening feeds and positioning. For mild GORD, antacids like alginate formulations are often used. For moderate to severe GORD, treatment typically combines a prokinetic agent to increase motility (such as domperidone or erythromycin) with an acid suppressant like ranitidine or a proton pump inhibitor like lansoprazole or omeprazole. The withdrawal of cisapride in 2000 and limitations of other prokinetic drugs like metoclopramide are also reviewed.
Healthy diet | Nutrition and Diet : weight loss Indiaweightlossindia
We are committed to helping you reach important weight loss goals and we are here to support you. Surgery is just one step on your journey.Following surgery, many patients lose weight rapidly.But it's important to make the commitment to a lifestyle of healthy eating and regular exercise.
The document summarizes the Ideal Protein Weight Loss Method. It was developed over 25 years ago in France and has been successfully used in Canada for 9 years. The method is a medically designed protocol that results in rapid fat loss while sparing muscle mass. It works by keeping protein intake at a minimum daily requirement to spare muscle, severely limiting carbohydrates to 30g per day to force the body into fat-burning ketosis, and eliminating most fats except essential fatty acids. This protocol targets fat loss specifically. It uses a variety of high protein foods and supplements to build complete low-carb meals while dieters consume non-starchy vegetables and salads for fiber. The method is effective for metabolic syndrome issues
This document discusses assessing a patient's diet and using low-calorie diets (LCD) and very low-calorie diets (VLCD) for weight loss and management. It provides information on factors that influence food choices, differences between plant-based and Western diets, strategies for changing diet and lifestyle, and using meal replacements and customizing protein intake as part of a weight loss plan.
Similar to Lovidia Appetite Suppressant and Natural Hunger Control Supplement (20)
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPsychoTech Services
A proprietary approach developed by bringing together the best of learning theories from Psychology, design principles from the world of visualization, and pedagogical methods from over a decade of training experience, that enables you to: Learn better, faster!
Travel vaccination in Manchester offers comprehensive immunization services for individuals planning international trips. Expert healthcare providers administer vaccines tailored to your destination, ensuring you stay protected against various diseases. Conveniently located clinics and flexible appointment options make it easy to get the necessary shots before your journey. Stay healthy and travel with confidence by getting vaccinated in Manchester. Visit us: www.nxhealthcare.co.uk
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptxHolistified Wellness
We’re talking about Vedic Meditation, a form of meditation that has been around for at least 5,000 years. Back then, the people who lived in the Indus Valley, now known as India and Pakistan, practised meditation as a fundamental part of daily life. This knowledge that has given us yoga and Ayurveda, was known as Veda, hence the name Vedic. And though there are some written records, the practice has been passed down verbally from generation to generation.
Osteoporosis - Definition , Evaluation and Management .pdfJim Jacob Roy
Osteoporosis is an increasing cause of morbidity among the elderly.
In this document , a brief outline of osteoporosis is given , including the risk factors of osteoporosis fractures , the indications for testing bone mineral density and the management of osteoporosis
Know the difference between Endodontics and Orthodontics.Gokuldas Hospital
Your smile is beautiful.
Let’s be honest. Maintaining that beautiful smile is not an easy task. It is more than brushing and flossing. Sometimes, you might encounter dental issues that need special dental care. These issues can range anywhere from misalignment of the jaw to pain in the root of teeth.
These lecture slides, by Dr Sidra Arshad, offer a simplified look into the mechanisms involved in the regulation of respiration:
Learning objectives:
1. Describe the organisation of respiratory center
2. Describe the nervous control of inspiration and respiratory rhythm
3. Describe the functions of the dorsal and respiratory groups of neurons
4. Describe the influences of the Pneumotaxic and Apneustic centers
5. Explain the role of Hering-Breur inflation reflex in regulation of inspiration
6. Explain the role of central chemoreceptors in regulation of respiration
7. Explain the role of peripheral chemoreceptors in regulation of respiration
8. Explain the regulation of respiration during exercise
9. Integrate the respiratory regulatory mechanisms
10. Describe the Cheyne-Stokes breathing
Study Resources:
1. Chapter 42, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 36, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 13, Human Physiology by Lauralee Sherwood, 9th edition
10 Benefits an EPCR Software should Bring to EMS Organizations Traumasoft LLC
The benefits of an ePCR solution should extend to the whole EMS organization, not just certain groups of people or certain departments. It should provide more than just a form for entering and a database for storing information. It should also include a workflow of how information is communicated, used and stored across the entire organization.
Histololgy of Female Reproductive System.pptxAyeshaZaid1
Dive into an in-depth exploration of the histological structure of female reproductive system with this comprehensive lecture. Presented by Dr. Ayesha Irfan, Assistant Professor of Anatomy, this presentation covers the Gross anatomy and functional histology of the female reproductive organs. Ideal for students, educators, and anyone interested in medical science, this lecture provides clear explanations, detailed diagrams, and valuable insights into female reproductive system. Enhance your knowledge and understanding of this essential aspect of human biology.
The skin is the largest organ and its health plays a vital role among the other sense organs. The skin concerns like acne breakout, psoriasis, or anything similar along the lines, finding a qualified and experienced dermatologist becomes paramount.
Test bank for karp s cell and molecular biology 9th edition by gerald karp.pdfrightmanforbloodline
Test bank for karp s cell and molecular biology 9th edition by gerald karp.pdf
Test bank for karp s cell and molecular biology 9th edition by gerald karp.pdf
Test bank for karp s cell and molecular biology 9th edition by gerald karp.pdf
Travel Clinic Cardiff: Health Advice for International TravelersNX Healthcare
Travel Clinic Cardiff offers comprehensive travel health services, including vaccinations, travel advice, and preventive care for international travelers. Our expert team ensures you are well-prepared and protected for your journey, providing personalized consultations tailored to your destination. Conveniently located in Cardiff, we help you travel with confidence and peace of mind. Visit us: www.nxhealthcare.co.uk
2. Ambra BioScience
Why?
Medical Science has made huge progress dealing with life-threatening
diseases and traumatic medical events. At the same time Americans have
steadily become less healthy due to the rise in chronic conditions such as
obesity and diabetes. Today, more than half of America’s healthcare dollars
are spent on lifestyle diseases that can be “treated” with diet and exercise.
We want to make America healthy again & do it without drugs. Our mission
is to help people everywhere measurably improve their health.
Live healthier, live happier, live longer!
Read on to learn about our science and our products.
2 Ambra BioScience CONFIDENTIAL
3. Gut Sensory Modulation (GSM) and
Lovidia®
• GSM Technology Platform
• Science & Patents
• Clinical Testing
• Lovidia Value Proposition
• Products
• LOVIDIA Way
3 Ambra BioScience CONFIDENTIAL
4. GSM Technology Overview
• Learnings from gastric-bypass surgery
• Physiology of L-cell hormone release
• L-cell gastrointestinal distribution
4 Ambra BioScience CONFIDENTIAL
Based on:
5. Learnings from gastric-bypass surgery
5 Ambra BioScience CONFIDENTIAL
GI manipulations that result in rapid
delivery of food to the lower bowel where
L-cells are most abundant lead to:
Improved glucose control prior to weight loss
Frequent remission of diabetes
Elevated circulating concentrations of GLP-1,
PYY and other gut hormones
Roux-en-Y
GI sleeve
6. L-cells release gut hormones that
mediate appetite and glucose regulation
6 Ambra BioScience CONFIDENTIAL
Gut Wall
CR
L-cell
Bitter
Sweet
Umami
GLP-1
PYY
Oxyntomodulin
Excreted
Hormones Target Organs ActivityBlood
Chemosensory
Receptor
Islet
Βeta Cell
Satiety
Meal cessation
Glucose/insulin
Regulation
Leveraging gut hormonal responses observed during ingestion of food
7. L-cell density is highest in the lower gut
7 Ambra BioScience CONFIDENTIAL
fundusfundus
<1<1antrumantrum
<1<1
duodenumduodenum
5.7 ± 0.95.7 ± 0.9
jejunumjejunum
4.7 ± 1.04.7 ± 1.0
ileumileum
84 ± 884 ± 8
ascendingascending
coloncolon
82 ± 982 ± 9
coloncolon
sigmoidsigmoid
coloncolon
196 ± 34196 ± 34
rectumrectum
480 ± 66480 ± 66
Adrian et al.,Adrian et al., GastroenterologyGastroenterology 1985; 89:1070-71985; 89:1070-7
~80 fold gradient in L-cell density from duodenum to rectum *
* Distribution assessed by PYY content (pmol/g)
pH 5-5.5
pH 6-6.5
pH 7.0
8. GSM Mode of Action
8 Ambra BioScience CONFIDENTIAL
The Science of Gut Sensory Modulation
• Deliver GRAS food ingredients to the lower gut to enhance
secretion of gluco-regulatory and satiety hormones (e.g.,
GLP-1, PYY) from enteroendocrine cells
9. Science Summary
Gut Sensory Modulation - proven platform
•Modulated release of endogenous gut
hormones (GLP-1, PYY…)
•Potential to deliver multiple high value
products (dietary supplements, medical foods,
food ingredients) that affect hunger, satiety,
glucose regulation, inflammatory response
and mood
9 Ambra BioScience CONFIDENTIAL
10. GSM Patents
10 Ambra BioScience CONFIDENTIAL
CHEMOSENSORY RECEPTOR
LIGAND-BASED THERAPIES
COMPOSITIONS AND METHODS
FOR HUNGER CONTROL AND
WEIGHT MANAGEMENT
(First Patent Filed: 2009)
(First Patent Filed: 2018)
Issued Patents: 15 (US 4, OUS 11)
Patents Pending: 9
11. GSM Clinical Testing Overview
Elcelyx Therapeutics Inc. invented the GSM technology platform. Ambra BioScience acquired the
GSM patent portfolio and Lovidia development program in 2014.
Multiple, placebo-controlled, acute GSM clinical studies conducted by Elcelyx between 2010 -
2013 showed that various tastants (alone and in combination) could stimulate the release of L-cell
hormones. Elcelyx also demonstrated in a 16-week, placebo-controlled, study that these same
tastants could produce statistically significant, categorical weight loss.
Ambra conducted a 1-week, 220-subject, double-blind, placebo-controlled clinical study with the
Lovidia® Hunger Control Formula in late 2015. Reduced hunger was the endpoint and the results
were statistically significant with a p-value = .02.
In 2017, Ambra conducted a 13-week health outcomes study involving 52 healthy subjects using
Lovidia in combination with intermittent fasting. Subjects lost an average of 14 lbs. (7 % reduction
in body weight) and significantly improved metabolic and cardiovascular indicators including
reduced blood pressure, and improved lipids and glucose control.
In 2017, Ambra conducted a 7-day hunger control and weight loss study using the Lovidia Hunger
Control Bar. The Bar group lost an average of 4 lbs. compared to 0.5 lbs. without the bars.
11 Ambra BioScience CONFIDENTIAL
12. GSM Clinical Evidence
Enhanced Hormone Release
12 Ambra BioScience CONFIDENTIAL
• Placebo-controlled, crossover, acute hormone release study
• Increased release of GLP-1 and PYY observed in study participants
taking GSM test formulation (LC001) compared to placebo
Baseline-corrected GLP1 Active
(Glucose Challenge N=12)
Time (min)
GLP-1active(pM)
-60 0 60 120 180 240 300
-5
0
5
10
Baseline-corrected GLP1 Active
(Ensure Challenge N=12)
Time (min)
GLP-1active(pM) -60 0 60 120 180 240 300
-5
0
5
10
Baseline-corrected PYY Total
(Glucose Challenge N=12)
talPYY(pg/mL)
0
10
20
30
Baseline-corrected PYY Total
(Ensure Challenge N=12)
talPYY(pg/mL)
0
10
20
30
Placebo
Active
*AUC P= 0.151
*Cmax P= 0.077
AUC P= 0.204
Cmax P= 0.021
GLP1 Active
ge N=12)
n)
80 240 300
Baseline-corrected GLP1 Active
(Ensure Challenge N=12)
Time (min)
GLP-1active(pM)
-60 0 60 120 180 240 300
-5
0
5
10
ed PYY Total
nge N=12)
Baseline-corrected PYY Total
(Ensure Challenge N=12)
talPYY(pg/mL)
0
10
20
30
Placebo
Active
*AUC P= 0.151
*Cmax P= 0.077
C P= 0.204
max P= 0.021
* Reproduced in 4 separate studies, total n=58
Baseline-corrected GLP1 Active
(Glucose Challenge N=12)
Time (min)
GLP-1active(pM)
-60 0 60 120 180 240 300
-5
0
5
10
Baseline-co
(Ensure
T
GLP-1active(pM)
-60 0 60
-5
0
5
10
Baseline-corrected PYY Total
(Glucose Challenge N=12)
Time (min)
TotalPYY(pg/mL)
-60 0 60 120 180 240 300
-20
-10
0
10
20
30
Baseline-co
(Ensure
T
TotalPYY(pg/mL)
-60 0 60
-20
-10
0
10
20
30
*AUC P= 0.151
*Cmax P= 0.077
AUC P= 0.204
Cmax P= 0.021
LC001 LC001
Glucose LoadGlucose Load
14. Clinically-proven to reduce hunger
14 Ambra BioScience CONFIDENTIAL
The commercial Lovidia Hunger Control Formula was tested in
220 subjects in a randomized, double-blind, placebo-controlled
study designed to evaluate the effectiveness of Lovidia to
reduce hunger over 7-day period
Study Results:
• Lovidia significantly more
effective than placebo,
p=0.02
• No safety flags noted
15. 13-week “LOVIDIA Way” lifestyle study using Lovidia in
conjunction with alternate-day caloric restriction
15 Ambra BioScience CONFIDENTIAL
Baseline
BMI
Average BMI
Average BMI
Change, (%)
P value
25 - 29.9
(n = 9)
28.3 -1.6, (-5.6%) 0.0029
30 - 34.9
(n = 14)
32.4 -1.8, (-5.6%) < 0.0001
35 -39.9
(n = 7)
37.3 -2.9, (-7.9%) 0.0089
40
(n = 8)
43.9 -3.0, (-6.8%) 0.0003
Average Weight Loss: 14 lbs.
Weight Loss Range: 3 lbs. - 51 lbs.
16. The LOVIDIA WAY study also resulted in significant
improvements in A1c, Lipids, Blood Pressure
16 Ambra BioScience CONFIDENTIAL
Baseline
Total/HDL
Cholesterol
N
Average Total/HDL
Cholesterol
P value
Baseline
Change
at Week
13
All 38 4.13 -0.357 0.0012
<3.5 14 2.95 -0.129 0.0823
> 3.5 24 4.82 -0.492 0.0035
Triglycerides
(mg/dL)
N
Average Triglycerides
(mg/dL)
P value
Baseline
Change at
Week 13
All 38 143.5 -19.68 0.0418
<150 24 100.1 2.33 0.7481
150 - 199 6 175.3 -27.83 0.2662
>200 8 250.0 -79.63 0.0188
≥ 150 14 218.0 -57.43 0.0084
Systolic/Diastolic
blood pressure
All
Normal
< 120/80
mmHg
Elevated
≥ 120/80
mmHg
High
≥ 140/90
mmHg
Average
MAP(mmHg)
113.75 106.87 116.21 125.31
Average Change in
MAP (mmHg)
-3.87 1.77 -5.88 -9.42
P value 0.05 0.66 0.01 0.02
N 38 10 28 12
Blood Pressure Lowering
Improved Lipids
Baseline
HbA1c
Category
N
Average HbA1c (%)
P valueBaselin
e
Week
13
Change
All 38 5.69 5.38 -0.31
<
0.0001
Normal 20 5.395 5.14 -0.26
<
0.0001
Prediabetes 17 5.92 5.64 -0.28 0.003
Diabetes 1 7.6 5.8 -1.8 -
Improved Glucose Control
17. Lovidia Value Proposition
• Clinically proven Lovidia Hunger Control products work in your lower gut to help you feel full
faster and lose weight all while living a full and happy life!
• Natural GRAS (Generally Recognized as Safe) Ingredients.
• Patented formulas based on $20 million dollars and 6 years of research.
• 1000’s of lives improved and counting!
17 Ambra BioScience CONFIDENTIAL
18. The Lovidia Products
• Lovidia products are designed to work with your
natural digestive process to reduce hunger and
help prevent overeating.
• Lovidia products help:
• Reduce snacking
• Give you more control over the amount of
food you eat
• Lose weight without having to fight hunger
18 Ambra BioScience CONFIDENTIAL
19. Lovidia Products
• Lovidia 3-Product Sample Pack for $19.95 lets you determine which products work best for you!
• Lovidia: All-natural Hunger Control Blend. Releases the blend over 1-3 hours in your gut.
• Lovidia XR (Extended Release): All-natural Hunger Control Blend. Releases the blend over 3-6
hours in your gut.
• Lovidia Bar: Use in conjunction with the tablets for a supercharged hunger control boost*
19 Ambra BioScience CONFIDENTIAL
20. Lovidia Value
• The Lovidia 3-Product
Sample Pack lets you
decide which products
work best for you!
• $19.95 + Free Shipping!
20 Ambra BioScience CONFIDENTIAL
21. Lovidia Products
• Lovidia Hunger Control Formula 30-count tablets
starting at $29.95, sold in 1, 2, or 3 bottle increments.
• Flip the switch on hunger! Lovidia Hunger Control
Formula targets the #1 obstacle to weight loss…
overeating. By working with your body’s own natural
hunger-control process, Lovidia’s patented formula
helps you feel satisfied with fewer calories, so you can
lose weight without dangerous stimulants or
unpleasant side effects. Ϯ
• All-natural, proprietary hunger-control blend
• No stimulants, diuretics, or negative side effects
• Non-GMO, Vegan, Gluten-free, Dairy-free
21 Ambra BioScience CONFIDENTIAL
22. Lovidia Products
• Lovidia XR 60-count tablets starting at $49.95.
• The Lovidia XR is designed to release slower in
the gut and target the L-cells lower in the
digestive system. Our research has shown that
for some people, a slower release is more
effective for hunger control.
• All-natural, proprietary hunger-control blend
• No stimulants, No caffeine, No diuretics
• Non-GMO, Dairy-free
22 Ambra BioScience CONFIDENTIAL
23. Lovidia Products
• Lovidia Hunger Control Bars starting at $2.95.
• Mixed Nuts
• Oats and Nuts
• The Lovidia Hunger Control Bars are made with
our scientific hunger control blend of ingredients
that keep you full and help crush cravings. These
small but mighty bars are 100% natural and
clinically proven to help you lose weight.
23 Ambra BioScience CONFIDENTIAL
24. Lovidia Products
• The LOVIDIA Way – Monthly Subscription - $89.95
• 60 Lovidia Tablets
• 12 Hunger Control Bars
• 12 Crispy Heart Sachets
• 4 complementary coaching calls
Developed from our 13-week Clinical Study with 52
participants that not only lost on average 14 lbs.
each but saw meaningful cardiovascular and
metabolic improvements.
24 Ambra BioScience CONFIDENTIAL
25. Lovidia Success Stories
• https://youtu.be/6-xSh_Ac-Oo
• Katrina lost 22 lbs. with the help of Lovidia.
25 Ambra BioScience CONFIDENTIAL
26. Lovidia Success Stories
• Tristin is down 2 pants sizes by using Lovidia products.
26 Ambra BioScience CONFIDENTIAL
Our area of focus in metabolic diseases and peptide/protein science.
We’ve been in business for almost 24 years and were able to successfully launch our first two first in class products, Symlin and Byetta, within months of each other in 2005.
We’re headquartered here in San Diego and have ~1500 employees with ~300 sales reps in the field and ~300 in our manufacturing facility in West Chester, OH.
Our area of focus in metabolic diseases and peptide/protein science.
We’ve been in business for almost 24 years and were able to successfully launch our first two first in class products, Symlin and Byetta, within months of each other in 2005.
We’re headquartered here in San Diego and have ~1500 employees with ~300 sales reps in the field and ~300 in our manufacturing facility in West Chester, OH.
Our area of focus in metabolic diseases and peptide/protein science.
We’ve been in business for almost 24 years and were able to successfully launch our first two first in class products, Symlin and Byetta, within months of each other in 2005.
We’re headquartered here in San Diego and have ~1500 employees with ~300 sales reps in the field and ~300 in our manufacturing facility in West Chester, OH.